Ultragenyx Pharmaceutical market cap RARE

Share price times shares outstanding: what the whole company sells for, since 2014.

Ultragenyx Pharmaceutical is worth $1.5B at the close on Oct 23, 2026, at $15.65 a share.

That is down 52% over the last year and down 73% over five years.

Its highest close in our data was $10.6B in Dec 2020.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$1.5B	$1.4B	$3.3B	−53%
2025	$3.3B	$2.5B	$4.2B	−18%
2024	$4B	$3.2B	$5.4B	+2%
2023	$3.9B	$2.3B	$3.9B	+21%
2022	$3.2B	$2.5B	$5.9B	−43%
2021	$5.7B	$5.2B	$10.1B	−32%
2020	$8.5B	$2.2B	$10.6B	+237%
2019	$2.5B	$2.1B	$3.8B	+18%
2018	$2.1B	$1.9B	$4.4B	+7%
2017	$2B	$1.9B	$3.7B	−31%
2016	$2.9B	$1.9B	$3.5B	−34%
2015	$4.4B	$1.5B	$5B	+210%
2014	$1.4B	$1B	$1.8B	n/a

Companies in Drug Manufacturers - General nearest Ultragenyx Pharmaceutical's size, closest first, today.

Company	Market cap
RAREUltragenyx Pharmaceutical	$1.5B
PAHCPhibro Animal Health	$1.6B
ANABAnaptysbio	$1.5B
PCRXPacira BioSciences	$1.5B
ANIPANI Pharmaceuticals	$1.7B
OMEROmeros	$1.2B
HRMYHarmony Biosciences	$2.1B
AMPHAmphastar Pharmaceuticals	$1.1B
PBHPrestige Consumer Healthcare	$2.3B
NRIXNurix Therapeutics	$2.8B
ABUSArbutus Biopharma	$831M
Peer median	$1.5B